Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » News & Analysis

News & Analysis


China biotech company and industry news and analysis...

Recent Articles

  Sinopharm Affiliate Pays $50 Million for Oramed's Oral Insulin Product
  Meinian Onehealth Tops Management's Offer for iKang Healthcare
  BGI Changes Direction at Complete Genomics; Cuts Staff
  Uni-Bio Science Acquires Rights to Jiangsu Hansoh's Diabetes Drug
  Lee's Pharma to Market Solasia's Anti-Nausea Patch in China
  Shenzhen Hepalink Invests $13 Million in Canada's OncoQuest
  ZAI Lab Acquires China Rights to Hanmi Lung Cancer Drug
  China's Spending for Drugs to Rise 6-9% during 2016-2020: IMS
  CFDA Issues New Drug/Clinical Trial Approval Regulations
  Tianjin Tasly Starts $784 Million China Healthcare Fund


ChinaBio® Events
Suzhou, China
May 18 - 19, 2016

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors